The Detection of Respiratory Syncytial Virus Antigen in Low Birth Weight Neonates 1454

1998 ◽  
Vol 43 ◽  
pp. 248-248
Author(s):  
Katherine M Knapp ◽  
Criag H Gilliam ◽  
Gordon E Schutze
Keyword(s):  
Respiratory Syncytial Virus ◽  
Birth Weight ◽  
Low Birth Weight ◽  
Virus Antigen ◽  
Respiratory Syncytial Virus Antigen ◽  
Syncytial Virus

Efficacy of Ribavirin Aerosol Treatment for Respiratory Syncytial Virus Bronchiolitis in Infants

1987 ◽  
Vol 15 (4) ◽  
pp. 227-233 ◽  
Author(s):  
G. Caramia ◽  
E. Palazzini
Keyword(s):  
Respiratory Syncytial Virus ◽  
Body Temperature ◽  
Marked Improvement ◽  
Virus Antigen ◽  
The Body ◽  
Viral Agent ◽  
Nasal Wash ◽  
Respiratory Syncytial Virus Antigen ◽  
Syncytial Virus ◽  
Therapeutic Selectivity

The therapeutic efficacy of ribavirin, an anti-viral agent with a broad spectrum of activity, was studied in 14 infants with bronchiolitis which, in seven cases, was caused by a respiratory syncytial virus infection. The drug was administered for 5–6 days using an aerosol in periods of either 4 or 6 h with an interval of either 4 or 2 h between administrations. The body temperature of patients with fever returned to normal by day 3 of therapy. A significant decrease in the respiratory rate occurred by day 2 when there was also a marked improvement in the subjective and objective symptomatology. The most significant clinical improvements occurred in infants presenting a respiratory syncytial virus antigen in nasal wash specimens. This suggests therapeutic selectivity by ribavirin for (or a more pronounced sensibility of) this virus.

Sign in / Sign up

Export Citation Format

Share Document